These results indicated that KCs specific-expressed WFDC12 in transgenic mice may influence lipid metabolism, oxidation-reduction reaction, inflammatory response, and skin barrier related molecules when applying IMQ-induced psoriasis, which resulted in more severe epidermal hyperplasia and inflammation response than WT mice. This evidence concerns the gene WFDC12 and psoriasis.